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Abstract 
High-performance liquid chromatography coupled with mass spectrometry plays a 
crucial role in drug analysis from biological materials, mainly due to its sensitivity, specificity 
and ability to provide structural information on the analytes. 
Multiple myeloma is a serious hematologic disease, accounting for about 1 % of all 
oncological diseases. New drugs from the group of proteasome inhibitors namely, 
carfilzomib and bortezomib represent a great promises for patients with relapsing multiple 
myeloma or in the case of the resistant to other anticancer drugs. 
The aim of this work was to develop pilot chromatographic conditions for HPLC-MS 
analysis of carfilzomib and bortezomib and evaluate different extraction of these drugs from 
plasma. Separation was carried out on an Ascentis column C18 10 x 3 mm, 3 µm, (Supelco, 
Germany). Electrospray ionization with ion trap mass analyzer were used in both cases. The 
mobile phase consisting of water and acetonitrile (20:80) was the most appropriate for 
carfilzomib. The flow rate of the mobile phase was set to 0.3 ml/min. For bortezomib, a 
mixture of 0.1% HCOOH and acetonitrile (35: 65) was chosen as the most suitable mobile 
phase. The mobile phase flow rate was 0.3 ml / min. A protein precipitation using 250 µl of 
acetonitrile with 0,01 % HCOOH per 50 μl of plasma was selected for carfilzomib. The same 
sample preparation method was chosen for bortezomib. However, in this case, higher 
volume of precipitating agents had to be used, namely 500 μl of acetonitrile with the 
addition of 0.1 % HCOOH. 
 
 
